A Distrofia Muscular Congênita (DMC) se caracteriza clinicamente por hipotonia e fraqueza muscular, retardo do desenvolvimento motor e retrações fibrotendíneas. Instrumentos de avaliação clínica, como as escalas funcionais, motoras e de qualidade de vida, têm como objetivo quantificar o impacto da doença sobre as atividades diárias da vida do paciente, além de auxiliarem na caracterização de grupos de estudo heterogêneos. Sendo a DMC altamente heterogênea, traçar o perfil funcional dos pacientes com diferentes subtipos seria útil para caracterizar padrões funcionais e auxiliar no tratamento em equipe multidisciplinar. Objetivos: Caracterizar o perfil de funcionalidade e qualidade de vida de pacientes com DMC de diferentes subtipos e correlacioná-lo com a força muscular e grau de amplitude de movimento. Metodologia: Em uma amostra de 18 pacientes com DMC com idade de 12 + 3,2 anos e 13 pacientes com outras miopatias congênitas com idade de 13 + 2,6 anos foram aplicados em três visitas (V1, V2 e V3) os questionários SF-36 e Índice de Barthel (IB), além de realizada avaliação físico-motora (goniometria, força muscular) seguido de correlação com a escala funcional MFM-32 (Medida de Função Motora). Resultados: Houve significativa queda na qualidade de vida em pacientes Merosina (-) e em outras formas de DMC. O índice de Barthel (IB) apontou \"grave dependência\" final em pacientes merosina (-) e \"moderada dependência\" em outras formas de DMC. A goniometria mostrou diminuição da movimentação global em todos os grupos articulares avaliados em pacientes com merosina (-). Em outras formas de DMC, houve exceção de diminuição apenas em articulação distal de membros superiores. A força de todos os grupos musculares é significativamente afetada em ambos os grupos. Pacientes merosina (-) mostram diminuição significativa de funcionalidade nas três dimensões da escala MFM-32 (D1, D2 e D3), e em outras formas de DMC, apenas diminuição em D2 e D3. Houve moderada correlação positiva entre força muscular e D1 da escala MFM-32, forte correlação positiva entre goniometria e D2 e D3 em pacientes com merosina (-), não havendo correlação entre nenhuma variável e MFM-32 em outras formas de DMC. Conclusão: Pacientes com DMC apresentaram perfil funcional \"gravemente dependente\", com diminuição da qualidade de vida, observada em cinco de oito quesitos do questionário SF-36. A força muscular e a amplitude de movimento articular foram afetadas de forma generalizada em ambos os grupos de pacientes. Pacientes com merosina (-) mostraram-se mais afetados funcionalmente em posturas eretas e transferências, sendo correlacionada positivamente com a força muscular dos grupos dessa tarefa / Congenital Muscular Dystrophy (CMD) is characterized by hypotonia and weakness, motor development delay and muscular contractures. Instruments of clinical assessment, such as functional motor and quality of life scales are essential to quantify the impact of the disease on daily activities of the patient\'s life in addition to helping in the characterization of heterogeneous study groups. As the DMC highly heterogeneous, trace the functional profile of patients with different subtypes would be useful to characterize functional patterns and aid in the treatment by a multidisciplinary team. Objectives: To characterize the functionality and quality of life of children with different subtypes of DMC and to correlate them with the degree of muscle strength and range of motion. Methods: In a sample of 18 patients with CMD (aged 12 + 3.2 years) and 13 patients with other congenital myopathies (aged 13 ± 2.6 years) were applied in three visits (V1, V2 and V3) the SF-36 and Barthel Index (BI), and performed physical-motor assessment (goniometry, muscle strength) followed by correlation with functional scale MFM-32 (motor Function Measure. ). Results: There was a significant decrease in the quality of life in patients Merosin (-) and other forms of CMD. IB indicated \"severe dependence\" final in Merosin patients (-) and \"moderate dependence\" in other forms of CMD. Goniometry showed a decrease of the overall joint movement in all groups evaluated in patients with merosin (-).In other forms of DMC was decreased joint movement in all joint groups, except for the distal joint of the upper limbs. The strength of each muscle group was significantly affected in both groups. Patients merosin (-) show a significant decrease in the functionality on the 3 dimensions of MFM-32 scale (D1, D2, D3) in patients with other forms of DMC only reduction in D2 and D3. There was a moderate positive correlation between muscle strength and D1 of the SF-32 scale, strong positive correlation between goniometry and D2 and D3 in patients with Merosin (-), there was no correlation between this variable and MFM-32 in other forms of CMD. Conclusion: Patients with CMD showed functional profile \"severely dependent\" to low quality of life observed in five of eight areas of the SF-36 questionnaire. Muscle strength and range of motion were affected in a generalized manner in both patient groups. Patients with Merosin (-) are even more affected functionally in standing and transfers being positively correlated with muscle strength of the groups of this task postures

Congenital myasthenic syndromes (CMS) are a group of heterogeneous disorders caused by mutations in genes encoding for proteins that are essential for neuromuscular transmission. All CMS share the clinical feature of fatigable muscle weakness. The differential diagnosis of CMS is wide, with a range of diseases going from autoimmune myasthenia gravis to muscle disorders. In this thesis, it was shown that measuring antibodies to clustered acetylcholine receptors (AChRs) by cell-based assay is helpful in the differential diagnosis of CMS. The findings of the current investigations showed that mutations in COL13A1, encoding the Collagen Type XIII α1 chain, were responsible for the symptoms of several patients with previously undefined myasthenias. In addition, this work described the clinical and complementary features of a novel CMS subtype due to mutations in the glycosylation pathway gene GMPPB. Investigations on a novel MUSK missense mutation (p.Ala617Val) uncovered previously unrecognised mechanisms of how levels of MuSK phosphorylation are critical to maintain synaptic structure, and guided suitable treatment for the patient. The study on the clinical and molecular basis of stridor, a novel clinical feature recently identified in patients with DOK7-CMS, prompted the identification of a novel DOK7 isoform, which warrants further investigation to elucidate its role in AChR clustering. Finally, the therapy of patients with severe AChR-deficiency was optimised thanks to a case series study that showed a robust improvement following the addition of β2-adrenergic agonists to their long-term treatment regime that included pyridostigmine.

Avec le besoin de développer un organe artificiel remplaçant le doigt humain dans le cas d'un déficit et la nécessité de comprendre le fonctionnement de ce système physiologique, un modèle physique inverse du système doigt, permettant de chercher les activations neuronales à partir du mouvement, est nécessaire. Malgré le grand nombre d'études dans la modélisation de la main humaine, presque il n'existe aucun modèle physique inverse du système doigt majeur qui s'intéresse à chercher les activations neuronales. Presque tous les modèles existants se sont intéressés à la recherche des forces et des activations musculaires. L'objectif de la thèse est de présenter un modèle neuromusculo-squelettique du système doigt majeur humain permettant d'obtenir les activations neuronales, les activations musculaires et les forces musculaires des tous les muscles agissants sur le système doigt d'après l'analyse du mouvement. Le but de ce type des modèles est de représenter les caractéristiques essentielles du mouvement avec le plus de réalisme possible. Notre travail consiste à étudier, modéliser et à simuler le mouvement du doigt humain. L'innovation du modèle proposé est le couplage entre la biomécanique et les aspects neurophysiologiques afin de simuler la chaine inverse complet du mouvement en allant des données dynamiques du doigt aux intentions neuronales qui contrôlent les activations musculaires. L'autre innovation est la conception d'un protocole expérimental spécifique qui traite à la fois les données sEMG multicanal et les données cinématiques d'après une procédure de capture de mouvement. / With the need to develop an artificial organ replacing the human finger in the case of a deficiency and the need to understand how this physiological system works, an inverse physical model of the finger system for estimating neuronal activations from the movement, is necessary. Despite the large number of studies in the human hand modeling, almost there is no inverse physical model of the middle finger system that focuses on search neuronal activations. Al most all existing models have focused on the research of the muscle forces and muscle activations. The purpose of the manuscript is to present a neuromusculoskeletal model of the human middle finger system for estimating neuronal activations, muscle activations and muscle forces of all the acting muscles after movement analysis. The aim of such models is to represent the essential characteristics of the movement with the best possible realism. Our job is to study, model and simulate the movement of the human finger. The innovation of the proposed model is the coupling between the biomechanical and neurophysiological aspects to simulate the complete inverse movement chain from dynamic finger data to neuronal intents that control muscle activations. Another innovation is the design of a specific experimental protocol that treats both the multichannel sEMG and kinematic data from a data capture procedure of the movement.

CAPES / Introdução: A estimulação elétrica funcional (FES) é aplicada a pessoas portadoras de lesão medular (LM) com o objetivo de gerar movimentos funcionais artificialmente. A Mecanomiografia (MMG) mede a oscilação do músculo durante a contração. Os padrões estimulatórios são determinados pelos parâmetros: períodos on e off do pulso e do burst e suas amplitudes. Durante a sessão de aplicação da FES, o tecido neuromuscular responde de forma variada em decorrência de alterações fisiológicas como fadiga muscular e/ou adaptação do motoneurônio. Objetivo: na pesquisa desenvolvida, investigou-se a influência dos parâmetros estimulatórios na eficiência da contração muscular evocada pela FES em voluntários hígidos e portadores de lesão medular. Materiais e Métodos: participaram da pesquisa 10 voluntários hígidos (VHs) e 10 voluntários com LM (VLMs) com sensores de MMG posicionados sobre os ventres musculares dos músculos reto femoral e vasto lateral. Os estímulos elétricos foram aplicados sobre o nervo femoral para ativação do músculo quadríceps. Foram testados cinco padrões estimulatórios em dias diferentes, com oito contrações evocadas artificialmente e divididas em duas sessões com intervalo de 15 min entre elas. Resultados: foi proposto um índice de eficiência de FES com (1) o tempo de estimulação, (2) a menor variação angular e (3) a menor divergência dos descritores de MMG: frequência mediana (Median Frequency) e valor eficaz (Root Mean Square). Os padrões estimulatórios que apresentaram maior eficiência são os de 50 Hz para VHs e 70 Hz para VLMs, por manterem a contração evocada artificialmente por (1) maior tempo, com menor (2) variação angular e (3) resposta mecanomiográfica com menor alteração. Conclusões: conclui-se que os padrões estimulatórios empregando frequências de 50 Hz para VHs e de 70 Hz para VLMs foram mais eficientes na contração artificial por meio da FES. / Introduction: Functional electrical stimulation (FES) is applied to people with spinal cord injury (SCI) in order to artificially evoque functional movements. Mechanomyography (MMG) measures the oscillation of the muscle during contraction. The stimulatory profiles are controlled by the parameters: active and rest periods of the pulse and the burst and their amplitude. During the period of application of FES, the neuromuscular tissue responds in different ways, due to physiological changes such as muscle fatigue and/or adaptation of motor neurons. Objective: In the research developed, we investigated the influence of simulatory parameters on the efficiency of muscle contraction evoked by FES in healthy volunteers and patients with spinal cord injury. Materials and Methods: The healthy volunteers (HV) and ten subjects with SCI participated of the study. The MMG sensors were placed over the belly of the rectus femoris muscle and vastus lateralis. The electrical stimuli were yielded on the femoral nerve in order to activate quadriceps muscle. Five FES profiles were tested on different days with eight artificially evoked contractions divided into two sessions with an interval of fifteen minutes apart. Results: was proposed a FES efficiency index based on (1) stimulation time, (2) lower angular variation and (3) lower divergence of MMG descriptors: Median Frequency (MF) and Root Mean Square (RMS) value. FES profiles that showed better efficiency are: burst frequency of 50 Hz for HV and 70 Hz for SCI volunteers. They kept the contraction artificially evoked for (1) longer time, (2) lower angular variation of and (3) mechanomyographic response with minor modification. Conclusions: we conclude thar stimulatory profiles using frequencies of 50 Hz for HV and 70 Hz for SCI volunteers were more efficient for evoking contraction artificially.

Des difficultés de compréhension interpersonnelles sont régulièrement rapportées par les proches et les patients atteints de Dystrophie Myotonique de type I (DM1) ou de Dystrophie Facio-Scapulo-Humérale (FSHD). Nous nous sommes intéressés à différents facteurs qui peuvent éclairer la présence d’un contresens relationnel au sein des couples (le patient avec son conjoint). Les facteurs étudiés sont : les troubles cognitifs, l’atteinte des mimiques faciales et le style d’attachement de chacun des partenaires. La méthode utilisée est basée en partie sur l’observation de l’interaction (communication verbale et non verbale) au sein des couples lors la réalisation d’une tâche de résolution de problème. Un test de reconnaissance des émotions faciales avec des visages atteints et des visages contrôles a également été construit et proposé à 57 sujets naïfs. Les résultats observés permettent de confirmer que l’atteinte du visage et de la cognition sociale (théorie de l’esprit) ainsi que le style d’attachement des membres du couple jouent un rôle dans les difficultés à se comprendre entre partenaires de l’interaction. Il est important de sensibiliser chacun des partenaires au rôle de la communication non verbale (CNV) dans leur quotidien. La CNV transmet non seulement des informations sur l’état interne (notamment les émotions) de l’autre, mais également sur ses besoins d’attention, de soutien, de support émotionnel. / Interpersonal communication difficulties are regularly reported by individuals suffering from Myotonic Dystrophy type I (DMI) and Facioscapulohumeral muscular Dystrophy (FSHD), and their families. Our study focuses specifically on communication between patients and their spouses. In order to investigate the nature of communication difficulties, cognitive impairment, impaired facial expression and the attachment styles of subjects were examined. Our investigation procedure involved detailed observation of couples’ communication processes (verbal and non-verbal communication) while completing a problem-solving task. Furthermore, we construct a test of facial emotion recognition composed of images from the DM1 and control groups, which was administered to 57 naive subjects. Results enables us to confirm that impaired facial expression, social cognition difficulties (theory of mind) and attachment style play a major role, in the communication and comprehension difficulties reported by patients and their families. A phenomenon of relational misinterpretation seems to occur between patients and their partners. It is therefore important to raise couples’ awareness of the role of non-verbal communication in everyday life. Non-verbal communication not only provides information about an individual’s internal state (such as emotions), but also about his or her needs for attention and emotional support.

Fundação de Amparo a Pesquisa do Estado de Alagoas / Esta pesquisa tem por objeto refletir sobre a expressão da vida psíquica do sujeito acometido pela Esclerose Lateral Amiotrófica (ELA), compreendida na vivência do seu corpo silenciado. Por esse termo designamos a peculiar condição do sujeito que, com o avanço da doença, tende a perder tanto a articulação da fala quanto dos movimentos, com um grave prejuízo em sua capacidade de se comunicar. Pretendemos compreender a expressão psíquica de tal sujeito a partir da interação dos cuidadores, familiares e profissionais de saúde no convívio com esse sujeito na fase avançada da doença. Utilizamos o método clínicoqualitativo de investigação (Turato, 2005), cuja pertinência à pesquisa humana em saúde está em buscar interpretar significados psicológicos e socioculturais trazidos por sujeitos afetados por doença, bem como dos cuidadores, familiares e profissionais. O número de participantes foi determinado pelo critério de saturação (Minayo, 1994), em que o pesquisador fecha o grupo quando determinado número de entrevistas já alcança o nível de informações esperadas. Coletamos depoimentos livres de oito participantes, sendo quatro profissionais de saúde com experiência no atendimento a casos de ELA: um neurologista, uma psicóloga, uma fonoaudióloga e uma fisioterapeuta, e quatro cuidadores e/ou familiares de pessoas acometidas pela ELA: uma filha de paciente, uma cuidadora contratada, uma esposa e uma viúva de paciente. Os participantes foram questionados a partir de dois aspectos de sua interação com o sujeito acometido pela ELA; em primeiro lugar, perguntamos de que modo, no convívio com o sujeito, conseguiam captar, interpretar e compreender suas vicissitudes. Em seguida, questionamos quais os recursos utilizados para o estabelecimento de uma comunicação intersubjetiva entre este profissional de saúde, familiar ou cuidador e o sujeito acometido pela ELA. Consideramos, finalmente, que a expressão-compreensão de vida psíquica do sujeito com ELA abrange uma gradação que vai desde elementos pragmáticos a posições relacionais por parte cuidadores, cuja complementaridade tem por efeito a apreensão dos conteúdos subjetivos dos pacientes

A Distrofia Muscular Congênita (DMC) se caracteriza clinicamente por hipotonia e fraqueza muscular, retardo do desenvolvimento motor e retrações fibrotendíneas. Instrumentos de avaliação clínica, como as escalas funcionais, motoras e de qualidade de vida, têm como objetivo quantificar o impacto da doença sobre as atividades diárias da vida do paciente, além de auxiliarem na caracterização de grupos de estudo heterogêneos. Sendo a DMC altamente heterogênea, traçar o perfil funcional dos pacientes com diferentes subtipos seria útil para caracterizar padrões funcionais e auxiliar no tratamento em equipe multidisciplinar. Objetivos: Caracterizar o perfil de funcionalidade e qualidade de vida de pacientes com DMC de diferentes subtipos e correlacioná-lo com a força muscular e grau de amplitude de movimento. Metodologia: Em uma amostra de 18 pacientes com DMC com idade de 12 + 3,2 anos e 13 pacientes com outras miopatias congênitas com idade de 13 + 2,6 anos foram aplicados em três visitas (V1, V2 e V3) os questionários SF-36 e Índice de Barthel (IB), além de realizada avaliação físico-motora (goniometria, força muscular) seguido de correlação com a escala funcional MFM-32 (Medida de Função Motora). Resultados: Houve significativa queda na qualidade de vida em pacientes Merosina (-) e em outras formas de DMC. O índice de Barthel (IB) apontou \"grave dependência\" final em pacientes merosina (-) e \"moderada dependência\" em outras formas de DMC. A goniometria mostrou diminuição da movimentação global em todos os grupos articulares avaliados em pacientes com merosina (-). Em outras formas de DMC, houve exceção de diminuição apenas em articulação distal de membros superiores. A força de todos os grupos musculares é significativamente afetada em ambos os grupos. Pacientes merosina (-) mostram diminuição significativa de funcionalidade nas três dimensões da escala MFM-32 (D1, D2 e D3), e em outras formas de DMC, apenas diminuição em D2 e D3. Houve moderada correlação positiva entre força muscular e D1 da escala MFM-32, forte correlação positiva entre goniometria e D2 e D3 em pacientes com merosina (-), não havendo correlação entre nenhuma variável e MFM-32 em outras formas de DMC. Conclusão: Pacientes com DMC apresentaram perfil funcional \"gravemente dependente\", com diminuição da qualidade de vida, observada em cinco de oito quesitos do questionário SF-36. A força muscular e a amplitude de movimento articular foram afetadas de forma generalizada em ambos os grupos de pacientes. Pacientes com merosina (-) mostraram-se mais afetados funcionalmente em posturas eretas e transferências, sendo correlacionada positivamente com a força muscular dos grupos dessa tarefa / Congenital Muscular Dystrophy (CMD) is characterized by hypotonia and weakness, motor development delay and muscular contractures. Instruments of clinical assessment, such as functional motor and quality of life scales are essential to quantify the impact of the disease on daily activities of the patient\'s life in addition to helping in the characterization of heterogeneous study groups. As the DMC highly heterogeneous, trace the functional profile of patients with different subtypes would be useful to characterize functional patterns and aid in the treatment by a multidisciplinary team. Objectives: To characterize the functionality and quality of life of children with different subtypes of DMC and to correlate them with the degree of muscle strength and range of motion. Methods: In a sample of 18 patients with CMD (aged 12 + 3.2 years) and 13 patients with other congenital myopathies (aged 13 ± 2.6 years) were applied in three visits (V1, V2 and V3) the SF-36 and Barthel Index (BI), and performed physical-motor assessment (goniometry, muscle strength) followed by correlation with functional scale MFM-32 (motor Function Measure. ). Results: There was a significant decrease in the quality of life in patients Merosin (-) and other forms of CMD. IB indicated \"severe dependence\" final in Merosin patients (-) and \"moderate dependence\" in other forms of CMD. Goniometry showed a decrease of the overall joint movement in all groups evaluated in patients with merosin (-).In other forms of DMC was decreased joint movement in all joint groups, except for the distal joint of the upper limbs. The strength of each muscle group was significantly affected in both groups. Patients merosin (-) show a significant decrease in the functionality on the 3 dimensions of MFM-32 scale (D1, D2, D3) in patients with other forms of DMC only reduction in D2 and D3. There was a moderate positive correlation between muscle strength and D1 of the SF-32 scale, strong positive correlation between goniometry and D2 and D3 in patients with Merosin (-), there was no correlation between this variable and MFM-32 in other forms of CMD. Conclusion: Patients with CMD showed functional profile \"severely dependent\" to low quality of life observed in five of eight areas of the SF-36 questionnaire. Muscle strength and range of motion were affected in a generalized manner in both patient groups. Patients with Merosin (-) are even more affected functionally in standing and transfers being positively correlated with muscle strength of the groups of this task postures

The most frequent sequelae following an obstetric brachial plexus lesion without complete functional recovery concern the impaired shoulder rotation movements and the associated structural changes of the growing glenohumeral joint. <p>This pathology is often unrecognized and may lead to a limitation in active movements, a pathologic and less efficient motion pattern in the affected limb, and the development of a severely incongruent and dysplastic glenohumeral joint prone to further arthrosis.<p><p>Hypothesis<p><p>Glenohumeral dysplasia after obstetric brachial plexus lesion has multiple etiologies: A hypothetic obstetric trauma may precede the motor imbalance, due to the initial palsy and prevalent recovery of the medial rotators of the shoulder.<p>The correction of the muscular imbalance, by neurotization of the lateral rotators (supra- and infraspinatus muscle) using a local nerve transfer or by a later muscle transfer surgery, improves function, seems to prevent the development of joint dysplasia and limits the articular deformities once they are present. <p>The early (peripartal) glenohumeral subluxation must be recognized and treated immediately to prevent the development of a severe joint contracture and dysplasia.<p> <p>Material and methods<p><p>Two retrospective and one prospective study evaluate how surgery may correct the muscular imbalance.<p>In a first series of 65 children, we analyse the recovery of the supra- and infraspinatus muscle after a nerve transfer onto the suprascapular nerve.<p>In a second retrospective analysis on 114 children, we study the outcome after secondary surgery (anterior joint release, modified Hoffer muscle transfer) dedicated to improve active and passive lateral rotation of the shoulder.<p>A prospective study of 50 magnetic resonance (MRI) scans of the glenohumeral joint describes the articular deformities.<p>Finally, 10 children presenting a very early glenohumeral subluxation have undergone a closed orthopaedic reposition and plaster immobilisation and were followed for a minimum of 2 years.<p><p>Results<p><p>In the first group, neurotization of the suprascapular nerve has been performed either by a dorsal or a ventral approach at a mean age of 14 months. The mean follow up is of 3 years and the improvement in aLR(ABD) is 68°and only 25°in aLR(ADD). None of these children with improved active lateral rotation of the shoulder developed clinical signs of a glenohumeral dysplasia within the follow up period.<p><p>Among the 114 children operated between 6 months and 44 years with a shoulder release, 74 had an isolated release procedure, 40 an associated tendon transfer or a suprascapular neurotization. The mean improvement in passive lateral rotation with the arm adducted (pLR (ADD)) was 60°. Active lateral rotation was possible in 63 % of children who underwent an isolated joint release.<p>The Hoffer muscle transfer was performed in 29 children and improved the aLR (ABD) by 60° (mean postoperative follow-up of 30 months). No signs of severe glenohumeral dysplasia developed in these children later on.<p><p>The prospective study of 50 consecutive MRI scans in children presenting at the consultation with a rotatory imbalance of their shoulder, as a sequel from obstetric brachial plexus palsy (Bahm et al. 2007) shows 37 congruent joints, 10 dorsal subluxations, 2 dorsal luxations and one complete dislocation associated with the formation of an independent neoglenoid. The humeral head was deformed in 12 cases; the glenoid in 34 children (flat in 23, biconcave 7 times, convex 3 times).<p><p>The follow up of 2 years in 10 children who underwent an immediate closed reposition shows evidence of joint congruence with a limited (30°) pLR (ADD), definitely lower than after a surgical release.<p><p>Conclusion<p><p>Some osteo-articular deformities secondary to neuromuscular diseases are well described ;those following an obstetric brachial plexus lesion are insufficiently recognized. Their etiology is unclear.<p>At the level of the shoulder joint, these sequels might be very important.<p>Our neuroorthopaedic hypothesis concerning a multifactorial etiology and treatment strategy raises the need of an early and precise screening of the deforming forces to render normal biomechanics and function.<p>The surgical strategy includes the reconstruction of the responsible motor nerve and the improvement of the passive and active range of motion of the shoulder in lateral rotation<p>It seems to be efficient to limit the progression to severe glenohumeral dysplasia and further arthrosis.<p> / Doctorat en Sciences médicales / info:eu-repo/semantics/nonPublished

Les maladies neuromusculaires génétiques (MNMs) sont des maladies rares et à ce titre elles ont été longtemps négligées. À l’heure actuelle, il existe peu de traitements pour les MNMs et ceux-ci sont encore symptomatiques. La prise en charge est donc principalement axée sur l'accompagnement et la prévention des atteintes fonctionnelles. Les mesures rapportées par les patients permettent d'évaluer le bénéfice perçu par les malades concernant leur prise en charge par les services de soins. Les mesures rapportées par les patients sont des indicateurs importants pour juger de l'efficacité des programmes de soins ou de réadaptation fonctionnelle. Pour mesurer la qualité de vie liée à la santé des patients adultes français atteints d'une MNM il n'existait que des outils génériques. Ce travail de doctorat a été réalisé sur les données recueillies dans huit centres de référence sur les MNMs français (Angers, Créteil, Garches, Lille, Nancy, Nice, Paris myologie, Reims) depuis 2006. Il a été réalisé en trois phases successives. Phase I: une analyse principalement qualitative des interactions verbales entre les participants de cinq groupes de discussion de patients atteints d'une MNM a permis de construire une banque d'items. Phase II: une analyse exploratoire principalement quantitative a permis de sélectionner les items de la banque afin de créer un nouveau questionnaire: le QoL-NMD. Phase III: une analyse de confirmation purement quantitative sur un échantillon distinct a permis de vérifier la validité des propriétés psychométriques du questionnaire QoL-NMD. / Due to their rarity genetic neuromuscular diseases (NMDs) have been neglected for a long time. Currently, there are few treatments available for NMDs and they are still symptomatic. The care is thus focus on the support and the prevention of health-related functional limitations. Patient reported outcome measures enable assessing patients' perceived benefit in medical care units. Patient-reported outcome measures are important indicators to assess the efficiency of medical care or rehabilitation programs. Only generic tools were available to measure quality of life for french adult patients with a NMD. This PhD work was carried out using data gathered from eight French NMD reference centers (Angers, Créteil, Garches, Lille, Nancy, Nice, Paris myologie, Reims) since 2006. It was realised into three successive phases. Phase I: a mainly qualitative analysis of verbal interactions between participants of five focus groups composed of patients with a NMD enabled the construction of an item bank. Phase II: a mainly quantitative exploratory analysis enabled to select the items from the bank in order to construct a new questionnaire: the QoL-NMD. Phase III: a purely quantitative confirmatory analysis on an independant sample enabled to verrify the Qol-NMD psychometric properties validity.

Objetivo: Determinar a responsividade do domínio subir e descer escada da escala de avaliação funcional em distrofia muscular de Duchenne (DMD), no período de um ano. Método: Participaram do estudo 26 pacientes com DMD. A análise utilizou o Tamanho do Efeito (ES) e a Média Padronizada de Resposta (SRM). Resultados: Atividade de subir escada: o ES mostrou responsividade baixa nos intervalos de avaliação de 3 meses (0,26; 0,35; 0,13; 0,17), baixa a moderada em 6 meses (0,58, 0,48; 0,33), moderada em 9 meses (0,70; 0,68) e alta em 1 ano (0,88). A análise com SRM mostrou responsividade baixa nos intervalos de avaliação de 3 meses (0,29; 0,38; 0,18 e 0,19), baixa a moderada em intervalos de 6 meses (0,59 e 0,51, 0,36), moderada em 9 meses (0,74 e 0,70) e alta em 1 ano (0,89). Atividade de descer escada: O ES apresentou responsividade baixa nos intervalos de avaliação de 3 meses (0,16; 0,25; 0,09; 0,08) e 6 meses (0,48; 0,35; 0,18), baixa a moderada em 9 meses (0,59, 0,44) e moderada em 1 ano (0,71). Análise com SRM mostrou responsividade baixa nos intervalos de 3 meses (0,25; 0,35; 0,12 e 0,09) e 6 meses (0,47; 0,38 e 0,21), moderada a baixa em 9 meses (0,62, 0,49) e moderada em 1 ano (0,74). Conclusão: A avaliação da atividade de subir escada, por meio da FES-DMD-D3, deve ser realizada em intervalos a partir de 9 meses, pois a responsividade é de moderada a alta. A avaliação do descer escadas deve ser realizada anualmente, pois houve responsividade moderada somente a partir de 12 meses / Objective: To determine the responsiveness of the domain up and down stair Functional Evaluation Scale for Duchenne Muscular Dystrophy (DMD) in one year follow-up. Method: The study included 26 patients with DMD. The analysis used the Effect Size (ES) and Standardized Response Mean (SRM) tests. Results: Climbing stairs activity: the ES test showed low responsiveness in the 3-month evaluation intervals (0.26; 0.35; 0.13; 0.17), low to moderate at 6 months (0.58, 0 48; 0.33), moderate in 9 months (0.70, 0.68) and high in one year (0.88). The SRM analysis showed low response in the 3 month evaluation interval (0.29, 0.38, 0.18 and 0.19), moderate to low every 6 months (0.59 and 51, 0, 36), moderate in 9 months (0.74 and 0.70) and high in one year (0.89). Down stairs activity: The ES test showed low responsiveness in the 3 month evaluation intervals (0.16; 0.25; 0.09; 0.08) and 6 months (0.48, 0.35, 0, 18), low to moderate at 9 months (0.59, 0.44) and moderate in 1 year (0.71). SRM Analysis showed low response at intervals of 3 months (0.25; 0.35; 0.12 and 0.09) and 6 months (0.47, 0.38 and 0.21), low to moderate 9 months (0.62, 0.49) and moderate in 1 year (0.74). Conclusion: The assessment of stair climbing up should be performed in 9 months or longer intervals, when responsiveness is moderate to high. Going down stairs assessment should be performed annually, because moderate responsiveness was observed in 1 year interval